Clicky

Neuropace, Inc.(NPCE)

Description: NeuroPace, Inc. operates as a medical device company in the United States. The company develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. Its RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.


Keywords: Neuroscience Epilepsy Neurophysiology Neurotechnology Seizure Neuromodulation Electroencephalography Neuroprosthetics Brain–Computer Interfacing

Home Page: www.neuropace.com

NPCE Technical Analysis

455 North Bernardo Avenue
Mountain View, CA 94043
United States
Phone: 650 237 2700


Officers

Name Title
Mr. Michael L. Favet Pres, CEO & Director
Ms. Irina Ridley Gen. Counsel & Corp. Sec.
Dr. Martha J. Morrell Chief Medical Officer
Ms. Rebecca L. Kuhn CFO, VP of Fin. & Admin. and Assistant Sec.
Ms. Chi Nguyen VP of Marketing
Mr. Mark S. Saxton VP of Sales
Ms. Irene Thomas VP of HR
Mr. Andre G. Marquette Chief Commercial Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.0097
Price-to-Sales TTM: 0.9055
IPO Date: 2021-04-22
Fiscal Year End: December
Full Time Employees: 174
Back to stocks